Montu revenues exceed $385m but profits slide amid rising competition

Montu saw profits tumble by almost a third in FY25 despite a sharp rise in revenue as increased competition and patient acquisition costs hit the bottom line.

While unaudited revenue climbed 46% to A$385 million – a solid number although below forecasts – it could not prevent after-tax profit sliding to $16.4m, 31% below the near-$24m posted in FY24.